Desna10的个人主页 - 老虎社区

Desna10

Desna10

-得道高升

IP属地：未知

315关注

29粉丝

0主题

0勋章

2021-12-19

$Tiger Brokers(TIGR)$Wow obvious attack from a group of price manipulators who bought puts at strike price 5 for profiteering..plus the fake news on that day to further help them... is there nothing Tiger Brokers can do to defend? we just sitting ducks?

2021-10-19

$Tiger Brokers(TIGR)$When will i see you again..... 💔

2021-10-06

Personally not using paypal for most payments.....

This Unstoppable Fintech Stock Is Getting Even Better. Can It Make You a Millionaire?

2021-11-11

$Tiger Brokers(TIGR)$Only left very little Mr Low selling low..... Waiting for Mr High now

2021-12-14

$Seagate Technology PLC(STX)$Up again [Miser]

2021-11-30

$Tiger Brokers(TIGR)$Seems like institutional share holders are increasing stakes

2021-11-03

$Tiger Brokers(TIGR)$i think their policy will shift a bit to benefit their businesses. Hopefully 1st overseas stock license will be given..... if not why so long no news.... if clearly illegal and they not considering regulating it.... they probably will immediately fine or charge themhttps://www.straitstimes.com/business/economy/xi-jinping-dials-back-chinas-economic-overhaul-as-masses-feel-pain

2021-11-14

seems like a leader.....

Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.

2021-11-08

$Seagate Technology PLC(STX)$To the moon

2021-11-02

$Tiger Brokers(TIGR)$back on the boat

2021-09-24

$GENTING SINGAPORE LIMITED(G13.SI)$waiting for 3rd quarter results.... and hope it is good

2021-11-04

A few are bubbles but mostly is inflation

Legendary investor Jeremy Grantham says US stocks are in a 'magnificent bubble' even crazier than in 1929 — here are 3 of his safe haven selections

2021-10-05

$Tiger Brokers(TIGR)$Tiger wake up

2021-12-16

$DiDi Global Inc.(DIDI)$Looks like buy back at 14 is possible with golden shares?

2021-10-07

$XIAOMI-W(01810)$looks like reach base alr

2021-10-04

sell off means buy in opportunity?

Market Sell-Off: 1 Tech Stock That Could Triple in 5 Years

2021-09-25

$Tiger Brokers(TIGR)$At the very beginning ....... meant to be?

2021-11-17

yeah weird .... the report is of no surprise.... it is expected to be loss.... haha the share price already accounted for this result [白眼]

@LWKJKK:$iQiyi Inc.(IQ)$its crazy, took 2 months to rise to 8.5, then now back again. Guess need to wait for CNY for this to soar again.

2021-10-29

$Tiger Brokers(TIGR)$My 1st heart break 😢

2021-10-28

$Tiger Brokers(TIGR)$888 good.... time to rise

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":4093674933944970,"uuid":"4093674933944970","gmtCreate":1630571869000,"gmtModify":1631097621047,"name":"Desna10","pinyin":"desna10","introduction":"","introductionEn":"","signature":"-得道高升","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":29,"headSize":315,"tweetSize":122,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.27","exceedPercentage":"60.91%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.27","exceedPercentage":"93.62%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":692084422,"gmtCreate":1640792564569,"gmtModify":1640792564917,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LPL\">$LG Display(LPL)$</a>Going up&nbsp;","listText":"<a href=\"https://laohu8.com/S/LPL\">$LG Display(LPL)$</a>Going up&nbsp;","text":"$LG Display(LPL)$Going up","images":[{"img":"https://static.tigerbbs.com/1d469e3a3dd1672742629fcebc8f211d","width":"1080","height":"3482"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692084422","isVote":1,"tweetType":1,"viewCount":650,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":699467582,"gmtCreate":1639878996929,"gmtModify":1639878997210,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Wow obvious attack from a group of&nbsp;price manipulators who bought puts at strike price 5 for profiteering..plus the fake news on that day to further help them... is there nothing Tiger Brokers can do to defend? we just sitting ducks?&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Wow obvious attack from a group of&nbsp;price manipulators who bought puts at strike price 5 for profiteering..plus the fake news on that day to further help them... is there nothing Tiger Brokers can do to defend? we just sitting ducks?&nbsp;","text":"$Tiger Brokers(TIGR)$Wow obvious attack from a group of price manipulators who bought puts at strike price 5 for profiteering..plus the fake news on that day to further help them... is there nothing Tiger Brokers can do to defend? we just sitting ducks?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/699467582","isVote":1,"tweetType":1,"viewCount":1797,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3479274787036362","authorId":"3479274787036362","name":"huuou","avatar":"https://static.laohu8.com/picture129","crmLevel":1,"crmLevelSwitch":0},"content":"股票交易有风险，散户必须谨慎交易。不过，我看好这家公司未来的业绩，因为它的业务发展空间广阔。","text":"股票交易有风险，散户必须谨慎交易。不过，我看好这家公司未来的业绩，因为它的业务发展空间广阔。","html":"股票交易有风险，散户必须谨慎交易。不过，我看好这家公司未来的业绩，因为它的业务发展空间广阔。"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690322943,"gmtCreate":1639639094070,"gmtModify":1639639566289,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/DIDI\">$DiDi Global Inc.(DIDI)$</a>Looks like buy back at 14 is possible with golden shares?","listText":"<a href=\"https://laohu8.com/S/DIDI\">$DiDi Global Inc.(DIDI)$</a>Looks like buy back at 14 is possible with golden shares?","text":"$DiDi Global Inc.(DIDI)$Looks like buy back at 14 is possible with golden shares?","images":[{"img":"https://static.tigerbbs.com/573073d8fc6d8342aa40b92ae8e4a84e","width":"1080","height":"952"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690322943","isVote":1,"tweetType":1,"viewCount":538,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":607856767,"gmtCreate":1639527542068,"gmtModify":1639527542272,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"🙏","listText":"🙏","text":"🙏","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607856767","repostId":"607312198","repostType":1,"repost":{"id":607312198,"gmtCreate":1639488854725,"gmtModify":1639488865533,"author":{"id":"3568580098685907","authorId":"3568580098685907","name":"2020TS","avatar":"https://static.tigerbbs.com/dc251ae3d7264077ed6557978fbfc6bb","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRAB\">$Grab Holdings(GRAB)$</a>Look Morgan Stanley projection. Hodl to moon👍💰🥳","listText":"<a href=\"https://laohu8.com/S/GRAB\">$Grab Holdings(GRAB)$</a>Look Morgan Stanley projection. Hodl to moon👍💰🥳","text":"$Grab Holdings(GRAB)$Look Morgan Stanley projection. Hodl to moon👍💰🥳","images":[{"img":"https://static.tigerbbs.com/ecd5ad9493c3058f4603153d73c1dd63","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607312198","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":611,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607971534,"gmtCreate":1639482201045,"gmtModify":1639482201247,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/STX\">$Seagate Technology PLC(STX)$</a>Up again&nbsp;[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/STX\">$Seagate Technology PLC(STX)$</a>Up again&nbsp;[Miser]&nbsp;","text":"$Seagate Technology PLC(STX)$Up again [Miser]","images":[{"img":"https://static.tigerbbs.com/a3485c21156adcb7f43c57ed8000dd9a","width":"1080","height":"3454"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/607971534","isVote":1,"tweetType":1,"viewCount":658,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":604467159,"gmtCreate":1639440032691,"gmtModify":1639440032935,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"pray&nbsp;","listText":"pray&nbsp;","text":"pray","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604467159","repostId":"604689957","repostType":1,"repost":{"id":604689957,"gmtCreate":1639386671867,"gmtModify":1639440648301,"author":{"id":"3519157433193136","authorId":"3519157433193136","name":"美港股观察社","avatar":"https://static.tigerbbs.com/cfcc85fddcd77379cda6138d51be4c17","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"关店300家，海底捞这次真的捞不动","htmlText":"\n \n \n  前段时间海底捞宣布关停300家门店的话题冲上了微博热搜第一，网友们纷纷感叹海底捞这次好像是真的捞不动了，门店的客流量也是肉眼可见的减少，负面新闻更是层出不穷，究竟是什么原因让海底捞从餐饮一哥跌落神坛呢？我们今天来分析一下。2019年算得上海底捞的巅峰时期，不论是业绩表现还是上市融资，都走的顺风顺水，也是这个时候，公司选择开店扩张，当然这也没毛病。然而到了疫情最严重的2020年，消费行业都在叫苦不迭，海底捞却选择反向操作，扩张的速度却有增无减，谁能抵挡得住租金减免、人工成本降低等一系列的低成本诱惑呢？于是，海底捞以平均每天新开1.5家的速度疯狂扩张。然而扩张带来的效果那叫一个惨，门店数量翻了将近一倍，但是营业收入仅增长了7.8%，净利润更是同比下降了87%之多，翻台率也从19年的4.8次每天下降到了3.5次每天。如果说2020年的业绩下坡路可以解释为受疫情的影响和成本投入的增多，那么2021年的操作着实让人匪夷所思了，仅上半年就疯狂开店299家，直接把翻台率拉胯到了3.1，单店净利不到6万元，要知道放在两年半之前，单店的净利还是150多万。股价也是一路下坡，从年初83块钱的高点跌到了如今的17块钱。市值也是跌跌不休，从4600亿港币的峰值缩水到不到千亿。当前的海底捞在一个热门商圈可以看到三四家甚至更多的门店，而客流量并不会因为门店数量的增加同比上升，自然导致客户出现了分流，运营成本提高，业绩下滑。造成这样的结果，海底捞创始人张勇也坦言是自己盲目自信，经营未达预期主要是由于快速扩张策略所导致的，说出了那句“目前的苦果只能由我们自己一口一口咽下去”的名言。那么，关店有用吗？如今的餐饮行业竞争激烈，特别是新的火锅品牌层出不穷，消费者也越来越挑剔，价格、口味、创新、服务缺一不可，让护城河本就不高的行业雪上加霜。海底捞要想回到当年的地位，仅靠割肉“慢下来”依旧困难重重。当然，海底捞也在\n \n","listText":"前段时间海底捞宣布关停300家门店的话题冲上了微博热搜第一，网友们纷纷感叹海底捞这次好像是真的捞不动了，门店的客流量也是肉眼可见的减少，负面新闻更是层出不穷，究竟是什么原因让海底捞从餐饮一哥跌落神坛呢？我们今天来分析一下。2019年算得上海底捞的巅峰时期，不论是业绩表现还是上市融资，都走的顺风顺水，也是这个时候，公司选择开店扩张，当然这也没毛病。然而到了疫情最严重的2020年，消费行业都在叫苦不迭，海底捞却选择反向操作，扩张的速度却有增无减，谁能抵挡得住租金减免、人工成本降低等一系列的低成本诱惑呢？于是，海底捞以平均每天新开1.5家的速度疯狂扩张。然而扩张带来的效果那叫一个惨，门店数量翻了将近一倍，但是营业收入仅增长了7.8%，净利润更是同比下降了87%之多，翻台率也从19年的4.8次每天下降到了3.5次每天。如果说2020年的业绩下坡路可以解释为受疫情的影响和成本投入的增多，那么2021年的操作着实让人匪夷所思了，仅上半年就疯狂开店299家，直接把翻台率拉胯到了3.1，单店净利不到6万元，要知道放在两年半之前，单店的净利还是150多万。股价也是一路下坡，从年初83块钱的高点跌到了如今的17块钱。市值也是跌跌不休，从4600亿港币的峰值缩水到不到千亿。当前的海底捞在一个热门商圈可以看到三四家甚至更多的门店，而客流量并不会因为门店数量的增加同比上升，自然导致客户出现了分流，运营成本提高，业绩下滑。造成这样的结果，海底捞创始人张勇也坦言是自己盲目自信，经营未达预期主要是由于快速扩张策略所导致的，说出了那句“目前的苦果只能由我们自己一口一口咽下去”的名言。那么，关店有用吗？如今的餐饮行业竞争激烈，特别是新的火锅品牌层出不穷，消费者也越来越挑剔，价格、口味、创新、服务缺一不可，让护城河本就不高的行业雪上加霜。海底捞要想回到当年的地位，仅靠割肉“慢下来”依旧困难重重。当然，海底捞也在","text":"前段时间海底捞宣布关停300家门店的话题冲上了微博热搜第一，网友们纷纷感叹海底捞这次好像是真的捞不动了，门店的客流量也是肉眼可见的减少，负面新闻更是层出不穷，究竟是什么原因让海底捞从餐饮一哥跌落神坛呢？我们今天来分析一下。2019年算得上海底捞的巅峰时期，不论是业绩表现还是上市融资，都走的顺风顺水，也是这个时候，公司选择开店扩张，当然这也没毛病。然而到了疫情最严重的2020年，消费行业都在叫苦不迭，海底捞却选择反向操作，扩张的速度却有增无减，谁能抵挡得住租金减免、人工成本降低等一系列的低成本诱惑呢？于是，海底捞以平均每天新开1.5家的速度疯狂扩张。然而扩张带来的效果那叫一个惨，门店数量翻了将近一倍，但是营业收入仅增长了7.8%，净利润更是同比下降了87%之多，翻台率也从19年的4.8次每天下降到了3.5次每天。如果说2020年的业绩下坡路可以解释为受疫情的影响和成本投入的增多，那么2021年的操作着实让人匪夷所思了，仅上半年就疯狂开店299家，直接把翻台率拉胯到了3.1，单店净利不到6万元，要知道放在两年半之前，单店的净利还是150多万。股价也是一路下坡，从年初83块钱的高点跌到了如今的17块钱。市值也是跌跌不休，从4600亿港币的峰值缩水到不到千亿。当前的海底捞在一个热门商圈可以看到三四家甚至更多的门店，而客流量并不会因为门店数量的增加同比上升，自然导致客户出现了分流，运营成本提高，业绩下滑。造成这样的结果，海底捞创始人张勇也坦言是自己盲目自信，经营未达预期主要是由于快速扩张策略所导致的，说出了那句“目前的苦果只能由我们自己一口一口咽下去”的名言。那么，关店有用吗？如今的餐饮行业竞争激烈，特别是新的火锅品牌层出不穷，消费者也越来越挑剔，价格、口味、创新、服务缺一不可，让护城河本就不高的行业雪上加霜。海底捞要想回到当年的地位，仅靠割肉“慢下来”依旧困难重重。当然，海底捞也在","images":[{"img":"https://static.tigerbbs.com/339f265b1817b6d4a501bca700ad7730","width":"0","height":"0"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604689957","isVote":1,"tweetType":2,"object":{"id":"a892b4cef93a4ba68ea4093de68412ea","tweetId":"604689957","videoUrl":"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/40dd5d11387702292811950750/YItkufEvHZUA.mp4","poster":"https://static.tigerbbs.com/339f265b1817b6d4a501bca700ad7730"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":593,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605041040,"gmtCreate":1639096349776,"gmtModify":1639096349942,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/STX\">$Seagate Technology PLC(STX)$</a>And the winner is?","listText":"<a href=\"https://laohu8.com/S/STX\">$Seagate Technology PLC(STX)$</a>And the winner is?","text":"$Seagate Technology PLC(STX)$And the winner is?","images":[{"img":"https://static.tigerbbs.com/7b45d840994349f6a9f1bcb41e2a8863","width":"1080","height":"3454"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605041040","isVote":1,"tweetType":1,"viewCount":709,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":602386054,"gmtCreate":1638972549918,"gmtModify":1638972550116,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LPL\">$LG Display(LPL)$</a>More pls","listText":"<a href=\"https://laohu8.com/S/LPL\">$LG Display(LPL)$</a>More pls","text":"$LG Display(LPL)$More pls","images":[{"img":"https://static.tigerbbs.com/009e5dd0c24d0de445fa3b70fb817836","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602386054","isVote":1,"tweetType":1,"viewCount":677,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":609140117,"gmtCreate":1638256914653,"gmtModify":1638256914752,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Seems like institutional share holders are increasing stakes","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Seems like institutional share holders are increasing stakes","text":"$Tiger Brokers(TIGR)$Seems like institutional share holders are increasing stakes","images":[{"img":"https://static.tigerbbs.com/99b62ff4f3b1a75f46ec592156a124e6","width":"1077","height":"914"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/609140117","isVote":1,"tweetType":1,"viewCount":1123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":876408922,"gmtCreate":1637335468225,"gmtModify":1637335468550,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Haha yeah they should have a hide function.....&nbsp;","listText":"Haha yeah they should have a hide function.....&nbsp;","text":"Haha yeah they should have a hide function.....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876408922","repostId":"876573965","repostType":1,"repost":{"id":876573965,"gmtCreate":1637334827165,"gmtModify":1637334827592,"author":{"id":"3575359596370479","authorId":"3575359596370479","name":"Sparky77","avatar":"https://static.tigerbbs.com/c836234cb7aec8b7d8754daee0f11731","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a> Seriously you guys should just put this stock in hibernation mode and come back to look at it once a month. If you look at this Tiger everyday, you will vomit blood. I feel so much happier when I look at my Nvidia and AMD. I have Tiger shares too, but I don't even look at it everyday. LOL!","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a> Seriously you guys should just put this stock in hibernation mode and come back to look at it once a month. If you look at this Tiger everyday, you will vomit blood. I feel so much happier when I look at my Nvidia and AMD. I have Tiger shares too, but I don't even look at it everyday. LOL!","text":"$Tiger Brokers(TIGR)$ Seriously you guys should just put this stock in hibernation mode and come back to look at it once a month. If you look at this Tiger everyday, you will vomit blood. I feel so much happier when I look at my Nvidia and AMD. I have Tiger shares too, but I don't even look at it everyday. LOL!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876573965","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":691,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878899472,"gmtCreate":1637163291892,"gmtModify":1637163291989,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"yeah weird .... the report is of no surprise.... it is expected to be loss.... haha the share price already accounted for this result&nbsp;[白眼]&nbsp;","listText":"yeah weird .... the report is of no surprise.... it is expected to be loss.... haha the share price already accounted for this result&nbsp;[白眼]&nbsp;","text":"yeah weird .... the report is of no surprise.... it is expected to be loss.... haha the share price already accounted for this result [白眼]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878899472","repostId":"878176795","repostType":1,"repost":{"id":878176795,"gmtCreate":1637162223118,"gmtModify":1637162223273,"author":{"id":"4096337009824130","authorId":"4096337009824130","name":"LWKJKK","avatar":"https://static.tigerbbs.com/c8865fe58cb1e2421bb5f60a39a8af3e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IQ\">$iQiyi Inc.(IQ)$</a>its crazy, took 2 months to rise to 8.5, then now back again. Guess need to wait for CNY for this to soar again.","listText":"<a href=\"https://laohu8.com/S/IQ\">$iQiyi Inc.(IQ)$</a>its crazy, took 2 months to rise to 8.5, then now back again. Guess need to wait for CNY for this to soar again.","text":"$iQiyi Inc.(IQ)$its crazy, took 2 months to rise to 8.5, then now back again. Guess need to wait for CNY for this to soar again.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878176795","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":337,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873720386,"gmtCreate":1636988099349,"gmtModify":1636988152217,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Back to life, back to realityBack to the here and now, yeahShow me how decideWhat you want from meTell me, maybe I could be there for you","listText":"Back to life, back to realityBack to the here and now, yeahShow me how decideWhat you want from meTell me, maybe I could be there for you","text":"Back to life, back to realityBack to the here and now, yeahShow me how decideWhat you want from meTell me, maybe I could be there for you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873720386","isVote":1,"tweetType":1,"viewCount":162,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873385397,"gmtCreate":1636859338992,"gmtModify":1636859339088,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"seems like a leader.....&nbsp;","listText":"seems like a leader.....&nbsp;","text":"seems like a leader.....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/873385397","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p>\n<p>“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p>\n<p>Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p>\n<p>Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p>\n<p>In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p>\n<p>The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p>\n<p>Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p>\n<p>The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p>\n<p>The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p>\n<p>The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p>\n<p>While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p>\n<p>In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p>\n<p>The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p>\n<p>“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p>\n<p>Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p>\n<p>“[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p>\n<p>The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p>\n<p>“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p>\n<p>Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p>\n<p>“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p>\n<p>Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p>\n<p>“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p>\n<p>That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p>\n<p>Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p>\n<p>Moderna shares are down more than 40% over the past three months.</p>\n<p>As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p>\n<p>When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p>\n<p>That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p>\n<p>Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p>\n<p>Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p>\n<p>An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that...</p>\n\n<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870134334,"gmtCreate":1636592527450,"gmtModify":1636592527548,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Only left very little Mr Low selling low..... Waiting for Mr High now&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Only left very little Mr Low selling low..... Waiting for Mr High now&nbsp;","text":"$Tiger Brokers(TIGR)$Only left very little Mr Low selling low..... Waiting for Mr High now","images":[{"img":"https://static.tigerbbs.com/0e45b002448a9de98301abf161113228","width":"1080","height":"3617"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/870134334","isVote":1,"tweetType":1,"viewCount":372,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":847141570,"gmtCreate":1636503348803,"gmtModify":1636503350658,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/STX\">$Seagate Technology PLC(STX)$</a>metaverse effect","listText":"<a href=\"https://laohu8.com/S/STX\">$Seagate Technology PLC(STX)$</a>metaverse effect","text":"$Seagate Technology PLC(STX)$metaverse effect","images":[{"img":"https://static.tigerbbs.com/1cec53aa476fb18f8b7803c4dca9061c","width":"1080","height":"3496"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847141570","isVote":1,"tweetType":1,"viewCount":228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":844662095,"gmtCreate":1636422922854,"gmtModify":1636424065155,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"JPMorgan said a total clampdown on existing business of the online brokers was unlikely, according to its research report dated October 28. “Our sensitivity test shows that assuming revenue contribution from mainland clients goes to zero in 2022, Futu would still be profit-making,” analyst Katherine Lei said.Seems like good estimates&nbsp;[得意]&nbsp;","listText":"JPMorgan said a total clampdown on existing business of the online brokers was unlikely, according to its research report dated October 28. “Our sensitivity test shows that assuming revenue contribution from mainland clients goes to zero in 2022, Futu would still be profit-making,” analyst Katherine Lei said.Seems like good estimates&nbsp;[得意]&nbsp;","text":"JPMorgan said a total clampdown on existing business of the online brokers was unlikely, according to its research report dated October 28. “Our sensitivity test shows that assuming revenue contribution from mainland clients goes to zero in 2022, Futu would still be profit-making,” analyst Katherine Lei said.Seems like good estimates [得意]","images":[{"img":"https://static.tigerbbs.com/549051ce076124671fcb8e7659f7bdd3","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844662095","isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":844864524,"gmtCreate":1636417307796,"gmtModify":1636417329124,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a>go go go&nbsp;","listText":"<a href=\"https://laohu8.com/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a>go go go&nbsp;","text":"$GENTING SINGAPORE LIMITED(G13.SI)$go go go","images":[{"img":"https://static.tigerbbs.com/30e1d6581312e49ee86bce4d5d339456","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844864524","isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":844868757,"gmtCreate":1636417091818,"gmtModify":1636417295080,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LPL\">$LG Display(LPL)$</a>go go go","listText":"<a href=\"https://laohu8.com/S/LPL\">$LG Display(LPL)$</a>go go go","text":"$LG Display(LPL)$go go go","images":[{"img":"https://static.tigerbbs.com/f7589fbd537c3a2002af10a2848c3448","width":"1080","height":"3617"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844868757","isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":845841667,"gmtCreate":1636330921494,"gmtModify":1636330921822,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/STX\">$Seagate Technology PLC(STX)$</a>To the moon","listText":"<a href=\"https://laohu8.com/S/STX\">$Seagate Technology PLC(STX)$</a>To the moon","text":"$Seagate Technology PLC(STX)$To the moon","images":[{"img":"https://static.tigerbbs.com/ecb770f1958238fac2f8cdfb7b02bf87","width":"1080","height":"3496"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/845841667","isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":845078133,"gmtCreate":1636257828842,"gmtModify":1636258043743,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LPL\">$LG Display(LPL)$</a>nice","listText":"<a href=\"https://laohu8.com/S/LPL\">$LG Display(LPL)$</a>nice","text":"$LG Display(LPL)$nice","images":[{"img":"https://static.tigerbbs.com/c6aaafd731ac88d618a0f297b08ca6b9","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845078133","isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"hots":[{"id":699467582,"gmtCreate":1639878996929,"gmtModify":1639878997210,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Wow obvious attack from a group of&nbsp;price manipulators who bought puts at strike price 5 for profiteering..plus the fake news on that day to further help them... is there nothing Tiger Brokers can do to defend? we just sitting ducks?&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Wow obvious attack from a group of&nbsp;price manipulators who bought puts at strike price 5 for profiteering..plus the fake news on that day to further help them... is there nothing Tiger Brokers can do to defend? we just sitting ducks?&nbsp;","text":"$Tiger Brokers(TIGR)$Wow obvious attack from a group of price manipulators who bought puts at strike price 5 for profiteering..plus the fake news on that day to further help them... is there nothing Tiger Brokers can do to defend? we just sitting ducks?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/699467582","isVote":1,"tweetType":1,"viewCount":1797,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3479274787036362","authorId":"3479274787036362","name":"huuou","avatar":"https://static.laohu8.com/picture129","crmLevel":1,"crmLevelSwitch":0},"content":"股票交易有风险，散户必须谨慎交易。不过，我看好这家公司未来的业绩，因为它的业务发展空间广阔。","text":"股票交易有风险，散户必须谨慎交易。不过，我看好这家公司未来的业绩，因为它的业务发展空间广阔。","html":"股票交易有风险，散户必须谨慎交易。不过，我看好这家公司未来的业绩，因为它的业务发展空间广阔。"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850557439,"gmtCreate":1634610758526,"gmtModify":1634610758795,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>When will i see you again..... 💔","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>When will i see you again..... 💔","text":"$Tiger Brokers(TIGR)$When will i see you again..... 💔","images":[{"img":"https://static.tigerbbs.com/80e1d1e2a2892c9978306d489507690c","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/850557439","isVote":1,"tweetType":1,"viewCount":312,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":829888596,"gmtCreate":1633486982265,"gmtModify":1633486982477,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Personally not using paypal for most payments.....&nbsp;","listText":"Personally not using paypal for most payments.....&nbsp;","text":"Personally not using paypal for most payments.....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/829888596","repostId":"2173301913","repostType":4,"repost":{"id":"2173301913","pubTimestamp":1633486823,"share":"https://www.laohu8.com/m/news/2173301913?lang=&edition=full","pubTime":"2021-10-06 10:20","market":"us","language":"en","title":"This Unstoppable Fintech Stock Is Getting Even Better. Can It Make You a Millionaire?","url":"https://stock-news.laohu8.com/highlight/detail?id=2173301913","media":"Motley Fool","summary":"This booming company just upgraded its app to add services and become a one-stop financial shop for its users.","content":"<p>With a stock price that has absolutely crushed the market over the past few years, <b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings</b> (NASDAQ:PYPL) is a business that's benefiting from the broad secular shift away from cash-based transactions. The company processed a whopping $1.1&nbsp;trillion&nbsp;in payment volume over the past 12 months, and there are now an incredible 403 million active accounts using PayPal's services.&nbsp;</p>\n<p>This leading fintech platform just released some significant updates to its consumer app, and that's investors have plenty to cheer about. Read on to see if PayPal is a millionaire-maker stock.&nbsp;</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7b415cf3c0f5052380718fa7b3f47e51\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>A new and improved financial sidekick&nbsp;</h2>\n<p>On Sept. 21, CEO Dan Shulman announced some highly anticipated upgrades to PayPal's mobile app:&nbsp;</p>\n<blockquote>\n We're excited to introduce the first version of the new PayPal app, a one-stop destination for our customers to take charge of their everyday financial lives, with new features like access to high yield savings, in-app shopping tools for customers to find deals and earn cash back rewards, early access Direct Deposit, and bill pay.\n</blockquote>\n<p>These upgrades are in addition to existing capabilities, like sending money to friends, making purchases with the buy now, pay later option, and paying for purchases with crypto.&nbsp;</p>\n<p>As it stands today, PayPal has 371&nbsp;million active consumer accounts. But Schulman isn't satisfied with this number. He wants the business to one day count 1 billion daily users, a huge jump from where things are today. The added features PayPal just revealed will certainly help achieve that lofty goal as people will start to view the app as a complete financial services tool.&nbsp;</p>\n<p>It's worth pointing out that PayPal is technically not a&nbsp;bank; it relies on third-party financial institutions to handle the behind-the-scenes banking-related activities. For example, the savings account, called PayPal Savings, will be offered by <b><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a></b>. The advantage with this strategy is that PayPal can focus its attention on gaining users and providing an easy-to-use consumer experience, while at the same time avoiding the onerous regulatory and compliance requirements needed to operate a bank. Synchrony, on the other hand, gets access to a wider audience which it wouldn't be able to reach otherwise. It's a win-win situation for both parties.&nbsp;</p>\n<p>It's also expected that PayPal will introduce stock market&nbsp;investing into the app in the near future, pitting it against a younger (but popular) service like <b>Robinhood Markets</b>. Although PayPal will certainly be late to the brokerage party, its massive existing user base trumps Robinhood's 21&nbsp;million&nbsp;active accounts.&nbsp;</p>\n<p>By 2025, the number of people who use digital wallets is expected to reach 4.4&nbsp;billion&nbsp;globally. And PayPal's recent initiatives, which emphasize simplicity and security, underscore the company's goal to be the main beneficiary of this push.&nbsp;</p>\n<h2>Is the stock a buy today?&nbsp;</h2>\n<p>PayPal's stock has been a&nbsp;longtime winner for shareholders, soaring more than sevenfold since June of 2015. I think the streak of outperformance, however, is far from over.&nbsp;</p>\n<p>First of all, the mobile app's&nbsp;enhancements are a perfect example of the optionality embedded in the business model, where the company can continually add more features in order to drive customer growth and higher engagement. PayPal says that the average account processed 43.5&nbsp;transactions&nbsp;over the past 12 months. Expect that figure to steadily march higher over time as customers' propensity to use PayPal for all their needs rises.&nbsp;</p>\n<p>And PayPal possesses stellar financial metrics. During the second quarter, the business produced a non-generally accepted accounting principles (GAAP)&nbsp;operating margin and net income margin of 26.5% and 21.8%, respectively. Additionally, only 4% of&nbsp;revenue&nbsp;is needed to invest in growth in any given year, so PayPal is able to return capital back to investors while still expanding at a rapid pace. So far in 2021, $1.5 billion of share repurchases have been executed.&nbsp;</p>\n<p>As you can see, PayPal is clearly an outstanding company. The ability and willingness to&nbsp;keep&nbsp;pushing the needle in the pursuit of becoming a single, comprehensive financial tool for its users will propel the business over the next several years. Rejuvenating the mobile app is a perfect example of this strategy.&nbsp;</p>\n<p>The growth this company continues to generate means that buying PayPal stock now and holding for the long term could put you on the path to becoming a millionaire.&nbsp;</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Unstoppable Fintech Stock Is Getting Even Better. Can It Make You a Millionaire?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Unstoppable Fintech Stock Is Getting Even Better. Can It Make You a Millionaire?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-06 10:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/05/unstoppable-fintech-stock-app-millionaire-paypal/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With a stock price that has absolutely crushed the market over the past few years, PayPal Holdings (NASDAQ:PYPL) is a business that's benefiting from the broad secular shift away from cash-based ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/05/unstoppable-fintech-stock-app-millionaire-paypal/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PYPL":"PayPal"},"source_url":"https://www.fool.com/investing/2021/10/05/unstoppable-fintech-stock-app-millionaire-paypal/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173301913","content_text":"With a stock price that has absolutely crushed the market over the past few years, PayPal Holdings (NASDAQ:PYPL) is a business that's benefiting from the broad secular shift away from cash-based transactions. The company processed a whopping $1.1 trillion in payment volume over the past 12 months, and there are now an incredible 403 million active accounts using PayPal's services. \nThis leading fintech platform just released some significant updates to its consumer app, and that's investors have plenty to cheer about. Read on to see if PayPal is a millionaire-maker stock. \nImage source: Getty Images.\nA new and improved financial sidekick \nOn Sept. 21, CEO Dan Shulman announced some highly anticipated upgrades to PayPal's mobile app: \n\n We're excited to introduce the first version of the new PayPal app, a one-stop destination for our customers to take charge of their everyday financial lives, with new features like access to high yield savings, in-app shopping tools for customers to find deals and earn cash back rewards, early access Direct Deposit, and bill pay.\n\nThese upgrades are in addition to existing capabilities, like sending money to friends, making purchases with the buy now, pay later option, and paying for purchases with crypto. \nAs it stands today, PayPal has 371 million active consumer accounts. But Schulman isn't satisfied with this number. He wants the business to one day count 1 billion daily users, a huge jump from where things are today. The added features PayPal just revealed will certainly help achieve that lofty goal as people will start to view the app as a complete financial services tool. \nIt's worth pointing out that PayPal is technically not a bank; it relies on third-party financial institutions to handle the behind-the-scenes banking-related activities. For example, the savings account, called PayPal Savings, will be offered by Synchrony Financial. The advantage with this strategy is that PayPal can focus its attention on gaining users and providing an easy-to-use consumer experience, while at the same time avoiding the onerous regulatory and compliance requirements needed to operate a bank. Synchrony, on the other hand, gets access to a wider audience which it wouldn't be able to reach otherwise. It's a win-win situation for both parties. \nIt's also expected that PayPal will introduce stock market investing into the app in the near future, pitting it against a younger (but popular) service like Robinhood Markets. Although PayPal will certainly be late to the brokerage party, its massive existing user base trumps Robinhood's 21 million active accounts. \nBy 2025, the number of people who use digital wallets is expected to reach 4.4 billion globally. And PayPal's recent initiatives, which emphasize simplicity and security, underscore the company's goal to be the main beneficiary of this push. \nIs the stock a buy today? \nPayPal's stock has been a longtime winner for shareholders, soaring more than sevenfold since June of 2015. I think the streak of outperformance, however, is far from over. \nFirst of all, the mobile app's enhancements are a perfect example of the optionality embedded in the business model, where the company can continually add more features in order to drive customer growth and higher engagement. PayPal says that the average account processed 43.5 transactions over the past 12 months. Expect that figure to steadily march higher over time as customers' propensity to use PayPal for all their needs rises. \nAnd PayPal possesses stellar financial metrics. During the second quarter, the business produced a non-generally accepted accounting principles (GAAP) operating margin and net income margin of 26.5% and 21.8%, respectively. Additionally, only 4% of revenue is needed to invest in growth in any given year, so PayPal is able to return capital back to investors while still expanding at a rapid pace. So far in 2021, $1.5 billion of share repurchases have been executed. \nAs you can see, PayPal is clearly an outstanding company. The ability and willingness to keep pushing the needle in the pursuit of becoming a single, comprehensive financial tool for its users will propel the business over the next several years. Rejuvenating the mobile app is a perfect example of this strategy. \nThe growth this company continues to generate means that buying PayPal stock now and holding for the long term could put you on the path to becoming a millionaire.","news_type":1},"isVote":1,"tweetType":1,"viewCount":154,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870134334,"gmtCreate":1636592527450,"gmtModify":1636592527548,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Only left very little Mr Low selling low..... Waiting for Mr High now&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Only left very little Mr Low selling low..... Waiting for Mr High now&nbsp;","text":"$Tiger Brokers(TIGR)$Only left very little Mr Low selling low..... Waiting for Mr High now","images":[{"img":"https://static.tigerbbs.com/0e45b002448a9de98301abf161113228","width":"1080","height":"3617"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/870134334","isVote":1,"tweetType":1,"viewCount":372,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":607971534,"gmtCreate":1639482201045,"gmtModify":1639482201247,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/STX\">$Seagate Technology PLC(STX)$</a>Up again&nbsp;[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/STX\">$Seagate Technology PLC(STX)$</a>Up again&nbsp;[Miser]&nbsp;","text":"$Seagate Technology PLC(STX)$Up again [Miser]","images":[{"img":"https://static.tigerbbs.com/a3485c21156adcb7f43c57ed8000dd9a","width":"1080","height":"3454"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/607971534","isVote":1,"tweetType":1,"viewCount":658,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":609140117,"gmtCreate":1638256914653,"gmtModify":1638256914752,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Seems like institutional share holders are increasing stakes","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Seems like institutional share holders are increasing stakes","text":"$Tiger Brokers(TIGR)$Seems like institutional share holders are increasing stakes","images":[{"img":"https://static.tigerbbs.com/99b62ff4f3b1a75f46ec592156a124e6","width":"1077","height":"914"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/609140117","isVote":1,"tweetType":1,"viewCount":1123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":848066964,"gmtCreate":1635948605874,"gmtModify":1635948757934,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>i think their policy will shift a bit to benefit their businesses. Hopefully 1st overseas stock license will be given..... if not why so long no news.... if clearly illegal and they not considering regulating it.... they probably will immediately fine or charge themhttps://www.straitstimes.com/business/economy/xi-jinping-dials-back-chinas-economic-overhaul-as-masses-feel-pain","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>i think their policy will shift a bit to benefit their businesses. Hopefully 1st overseas stock license will be given..... if not why so long no news.... if clearly illegal and they not considering regulating it.... they probably will immediately fine or charge themhttps://www.straitstimes.com/business/economy/xi-jinping-dials-back-chinas-economic-overhaul-as-masses-feel-pain","text":"$Tiger Brokers(TIGR)$i think their policy will shift a bit to benefit their businesses. Hopefully 1st overseas stock license will be given..... if not why so long no news.... if clearly illegal and they not considering regulating it.... they probably will immediately fine or charge themhttps://www.straitstimes.com/business/economy/xi-jinping-dials-back-chinas-economic-overhaul-as-masses-feel-pain","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/848066964","isVote":1,"tweetType":1,"viewCount":920,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873385397,"gmtCreate":1636859338992,"gmtModify":1636859339088,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"seems like a leader.....&nbsp;","listText":"seems like a leader.....&nbsp;","text":"seems like a leader.....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/873385397","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p>\n<p>“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p>\n<p>Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p>\n<p>Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p>\n<p>In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p>\n<p>The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p>\n<p>Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p>\n<p>The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p>\n<p>The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p>\n<p>The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p>\n<p>While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p>\n<p>In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p>\n<p>The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p>\n<p>“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p>\n<p>Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p>\n<p>“[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p>\n<p>The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p>\n<p>“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p>\n<p>Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p>\n<p>“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p>\n<p>Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p>\n<p>“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p>\n<p>That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p>\n<p>Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p>\n<p>Moderna shares are down more than 40% over the past three months.</p>\n<p>As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p>\n<p>When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p>\n<p>That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p>\n<p>Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p>\n<p>Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p>\n<p>An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that...</p>\n\n<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845841667,"gmtCreate":1636330921494,"gmtModify":1636330921822,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/STX\">$Seagate Technology PLC(STX)$</a>To the moon","listText":"<a href=\"https://laohu8.com/S/STX\">$Seagate Technology PLC(STX)$</a>To the moon","text":"$Seagate Technology PLC(STX)$To the moon","images":[{"img":"https://static.tigerbbs.com/ecb770f1958238fac2f8cdfb7b02bf87","width":"1080","height":"3496"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/845841667","isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":843134259,"gmtCreate":1635812283087,"gmtModify":1635812283231,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>back on the boat&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>back on the boat&nbsp;","text":"$Tiger Brokers(TIGR)$back on the boat","images":[{"img":"https://static.tigerbbs.com/b2adec22596febd151a23854764ae3b5","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/843134259","isVote":1,"tweetType":1,"viewCount":121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":861998397,"gmtCreate":1632446719019,"gmtModify":1632723691415,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a>waiting for 3rd quarter results.... and hope it is good","listText":"<a href=\"https://laohu8.com/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a>waiting for 3rd quarter results.... and hope it is good","text":"$GENTING SINGAPORE LIMITED(G13.SI)$waiting for 3rd quarter results.... and hope it is good","images":[{"img":"https://static.tigerbbs.com/7a629595164a412c037fc6d7dd678860","width":"1080","height":"3511"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/861998397","isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":848534056,"gmtCreate":1636011084236,"gmtModify":1636011084515,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"A few are bubbles but mostly is inflation","listText":"A few are bubbles but mostly is inflation","text":"A few are bubbles but mostly is inflation","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848534056","repostId":"2180763679","repostType":4,"repost":{"id":"2180763679","pubTimestamp":1635992160,"share":"https://www.laohu8.com/m/news/2180763679?lang=&edition=full","pubTime":"2021-11-04 10:16","market":"us","language":"en","title":"Legendary investor Jeremy Grantham says US stocks are in a 'magnificent bubble' even crazier than in 1929 — here are 3 of his safe haven selections","url":"https://stock-news.laohu8.com/highlight/detail?id=2180763679","media":"MoneyWise","summary":"Jeremy Grantham, legendary investor and a pioneer of index fund investing, has added his voice to th","content":"<p><img src=\"https://static.tigerbbs.com/c9fa7ef14c316fc50ef6c3a4f3b73c9f\" tg-width=\"1800\" tg-height=\"800\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Jeremy Grantham, legendary investor and a pioneer of index fund investing, has added his voice to the chorus of financial wizards who expect today’s runaway stock market to soon hit the wall.</p>\n<p>Grantham recently told CNBC that equities in the U.S. are in a “magnificent bubble,” larger even than those in 1929 and 2000, which kicked off the Great Depression and signaled the end of the dotcom bubble, respectively.</p>\n<p>Grantham’s worth listening to.</p>\n<p>He predicted the dotcom collapse and the 2008 meltdown of the real estate market. He’s also in charge of about $60 billion as the investment chief at asset management firm Grantham, Mayo, &amp; Otterloo.</p>\n<p>Even though the market has surged further since Grantham’s comments, let’s look at a few safe haven stocks in GMO’s portfolio. One of them might be worth buying with some of your spare pennies.</p>\n<h2>UnitedHealth (UNH)</h2>\n<p>UnitedHealth’s dividend payout, currently $1.45 per share, and the performance of its shares, which are up almost 30% this year, make the company an attractive buy right now.</p>\n<p>But the insurance and healthcare leader is well positioned to weather any long-term financial tumult as well.</p>\n<p>Regardless of what happens to the economy, Americans are still going to need healthcare, and millions of them are already UnitedHealth customers.</p>\n<p>UnitedHealth is a diversified company. In addition to its thriving insurance business, it also provides software and information technology to a number of clinics and hospitals.</p>\n<p>As the medical tech space continues to grow, so should UnitedHealth’s profits.</p>\n<h2>U.S. Bancorp (USB)</h2>\n<p>U.S. Bancorp is the parent company of U.S. Bank, <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the country’s largest banking institutions.</p>\n<p>Betting on bank stock might seem counterintuitive when a stock market correction is expected to hammer investors’ finances. But banks tend to do well in rising interest rate environments: As rates increase, the profit margin, or spread, earned by banks widens.</p>\n<p>Rather than turning itself into a casino through the kinds of risky derivative plays that tanked some of its competitors in 2007-2008, U.S. Bancorp has instead been focused on innovating and providing digital service for its customers.</p>\n<p>The increased efficiency and lower operating costs that result should be music to investors’ ears.</p>\n<p>Since the beginning of 2021, U.S. Bancorp stock has risen by almost 32%. Of course, if you’re on the fence about jumping in at the current level, some apps might give you a free share of U.S. Bancorp just for signing up.</p>\n<h2>Coca-Cola (KO)</h2>\n<p>There may no longer be any actual coke in Coke, but the company’s shares are still pretty addictive.</p>\n<p>Despite the push for more healthy food and beverage consumption, Coca-Cola’s dominance of the soft drink market remains unmatched.</p>\n<p>But the company’s offerings extend far beyond liquid sugar.</p>\n<p>Coke also sells popular bottled water brands Dasani and Smartwater, big-name juices like Minute Maid and Simply, and international coffee products Costa and Georgia.</p>\n<p>What makes Coca-Cola an interesting defensive play is the company’s consistently impressive profit margin, which has averaged 23.6% over the last decade. That’s largely the result of Coke’s ability to tinker with portion sizes and prices and having the capital to invest in greater productivity.</p>\n<p>A faltering stock market shouldn’t change any of those dynamics.</p>\n<p>This year, Coke’s quarterly dividend payout hit $0.42, almost double what it was in 2011.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Legendary investor Jeremy Grantham says US stocks are in a 'magnificent bubble' even crazier than in 1929 — here are 3 of his safe haven selections</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLegendary investor Jeremy Grantham says US stocks are in a 'magnificent bubble' even crazier than in 1929 — here are 3 of his safe haven selections\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 10:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/legendary-investor-jeremy-grantham-says-203300474.html><strong>MoneyWise</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Jeremy Grantham, legendary investor and a pioneer of index fund investing, has added his voice to the chorus of financial wizards who expect today’s runaway stock market to soon hit the wall.\nGrantham...</p>\n\n<a href=\"https://finance.yahoo.com/news/legendary-investor-jeremy-grantham-says-203300474.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"USB":"美国合众银行","UNH":"联合健康","KO":"可口可乐"},"source_url":"https://finance.yahoo.com/news/legendary-investor-jeremy-grantham-says-203300474.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2180763679","content_text":"Jeremy Grantham, legendary investor and a pioneer of index fund investing, has added his voice to the chorus of financial wizards who expect today’s runaway stock market to soon hit the wall.\nGrantham recently told CNBC that equities in the U.S. are in a “magnificent bubble,” larger even than those in 1929 and 2000, which kicked off the Great Depression and signaled the end of the dotcom bubble, respectively.\nGrantham’s worth listening to.\nHe predicted the dotcom collapse and the 2008 meltdown of the real estate market. He’s also in charge of about $60 billion as the investment chief at asset management firm Grantham, Mayo, & Otterloo.\nEven though the market has surged further since Grantham’s comments, let’s look at a few safe haven stocks in GMO’s portfolio. One of them might be worth buying with some of your spare pennies.\nUnitedHealth (UNH)\nUnitedHealth’s dividend payout, currently $1.45 per share, and the performance of its shares, which are up almost 30% this year, make the company an attractive buy right now.\nBut the insurance and healthcare leader is well positioned to weather any long-term financial tumult as well.\nRegardless of what happens to the economy, Americans are still going to need healthcare, and millions of them are already UnitedHealth customers.\nUnitedHealth is a diversified company. In addition to its thriving insurance business, it also provides software and information technology to a number of clinics and hospitals.\nAs the medical tech space continues to grow, so should UnitedHealth’s profits.\nU.S. Bancorp (USB)\nU.S. Bancorp is the parent company of U.S. Bank, one of the country’s largest banking institutions.\nBetting on bank stock might seem counterintuitive when a stock market correction is expected to hammer investors’ finances. But banks tend to do well in rising interest rate environments: As rates increase, the profit margin, or spread, earned by banks widens.\nRather than turning itself into a casino through the kinds of risky derivative plays that tanked some of its competitors in 2007-2008, U.S. Bancorp has instead been focused on innovating and providing digital service for its customers.\nThe increased efficiency and lower operating costs that result should be music to investors’ ears.\nSince the beginning of 2021, U.S. Bancorp stock has risen by almost 32%. Of course, if you’re on the fence about jumping in at the current level, some apps might give you a free share of U.S. Bancorp just for signing up.\nCoca-Cola (KO)\nThere may no longer be any actual coke in Coke, but the company’s shares are still pretty addictive.\nDespite the push for more healthy food and beverage consumption, Coca-Cola’s dominance of the soft drink market remains unmatched.\nBut the company’s offerings extend far beyond liquid sugar.\nCoke also sells popular bottled water brands Dasani and Smartwater, big-name juices like Minute Maid and Simply, and international coffee products Costa and Georgia.\nWhat makes Coca-Cola an interesting defensive play is the company’s consistently impressive profit margin, which has averaged 23.6% over the last decade. That’s largely the result of Coke’s ability to tinker with portion sizes and prices and having the capital to invest in greater productivity.\nA faltering stock market shouldn’t change any of those dynamics.\nThis year, Coke’s quarterly dividend payout hit $0.42, almost double what it was in 2011.","news_type":1},"isVote":1,"tweetType":1,"viewCount":134,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820227054,"gmtCreate":1633396936230,"gmtModify":1633397055084,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Tiger wake up&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Tiger wake up&nbsp;","text":"$Tiger Brokers(TIGR)$Tiger wake up","images":[{"img":"https://static.tigerbbs.com/3359549fd773ade3184fccfc3b0ba30f","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820227054","isVote":1,"tweetType":1,"viewCount":81,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":690322943,"gmtCreate":1639639094070,"gmtModify":1639639566289,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/DIDI\">$DiDi Global Inc.(DIDI)$</a>Looks like buy back at 14 is possible with golden shares?","listText":"<a href=\"https://laohu8.com/S/DIDI\">$DiDi Global Inc.(DIDI)$</a>Looks like buy back at 14 is possible with golden shares?","text":"$DiDi Global Inc.(DIDI)$Looks like buy back at 14 is possible with golden shares?","images":[{"img":"https://static.tigerbbs.com/573073d8fc6d8342aa40b92ae8e4a84e","width":"1080","height":"952"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690322943","isVote":1,"tweetType":1,"viewCount":538,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":823047177,"gmtCreate":1633567854756,"gmtModify":1633567933722,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01810\">$XIAOMI-W(01810)$</a>looks like reach base alr","listText":"<a href=\"https://laohu8.com/S/01810\">$XIAOMI-W(01810)$</a>looks like reach base alr","text":"$XIAOMI-W(01810)$looks like reach base alr","images":[{"img":"https://static.tigerbbs.com/22edf94150d703494989ed4f39ab595c","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823047177","isVote":1,"tweetType":1,"viewCount":95,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":820157496,"gmtCreate":1633361216557,"gmtModify":1633361216782,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"sell off means buy in opportunity?","listText":"sell off means buy in opportunity?","text":"sell off means buy in opportunity?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820157496","repostId":"2172799574","repostType":4,"repost":{"id":"2172799574","pubTimestamp":1633358220,"share":"https://www.laohu8.com/m/news/2172799574?lang=&edition=full","pubTime":"2021-10-04 22:37","market":"us","language":"en","title":"Market Sell-Off: 1 Tech Stock That Could Triple in 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2172799574","media":"Motley Fool","summary":"Fastly's share price has taken a beating over the last year.","content":"<p>Last week, all three major U.S. indices took a hit, though the tech-heavy <b>Nasdaq Composite</b> fell further than the <b>S&amp;P 500</b> or the <b>Dow Jones Industrial Average</b>. Unfortunately, this sell-off added to the pain of previous losses for some shareholders, myself included. For instance, <b>Fastly</b> (NYSE:FSLY) stock is now down about 70% from its all-time high.</p>\n<p>However, dips in the market can be buying opportunities when we are talking about a good company, especially if the company in question still has strong prospects for future growth. And I think Fastly checks that box. In fact, I think this tech stock could grow threefold in the next five years.</p>\n<p>Here's why.</p>\n<h2>The promise of edge computing</h2>\n<p>Fastly makes the internet faster. Its edge cloud platform accelerates and secures the delivery of content (e.g. applications, streaming media), ensuring a good experience for end-users like you and me. To do this, Fastly's global network -- composed of servers strategically positioned near internet exchange points -- sits between its customers' data centers and their end users' devices, effectively reducing the distance data must travel to reach its destination.</p>\n<p>Why does this matter? Latency makes for a poor user experience. If a website or mobile app loads too slowly, people tend to abandon the service. This truth is made more pressing by digital transformation. As more companies engage with consumers through the internet, providing a high-quality digital experience becomes more critical.</p>\n<p>To that end, Fastly puts its market opportunity at $36.2 billion by 2022.</p>\n<h2>Competitive position</h2>\n<p>Fastly built its edge cloud for the modern internet. Its network is composed of fewer, more powerful&nbsp;servers than traditional content delivery networks like <b>Akamai</b>. That means its edge cloud can handle more requests more quickly, so fewer requests are routed back to the client's data center. In turn, that translates into better performance and cost savings.</p>\n<p>Fastly also benefits from its cloud-agnostic position, meaning its platform is not associated with or biased toward any public cloud, like<b> Microsoft</b> Azure or <b>Amazon </b>Web Services (AWS). Fastly works with all of them, intelligently routing traffic across different infrastructures. This means its clients can work with their preferred cloud vendors while monitoring all networks from a single platform.</p>\n<h2>Financial performance</h2>\n<p>During the second quarter of 2021, an outage in Fastly's network caused a significant disruption for many websites, leading the company to post lackluster financial results. Revenue grew just 14%, and management lowered guidance for the third quarter. Even worse, CEO Joshua Bixby noted that a large customer had not yet returned to the platform as of the Q2 earnings call.</p>\n<p>According to CDN Planet, this unnamed customer is likely Amazon, since the retail giant stopped using Fastly shortly after the outage. However, Amazon did return to the platform in August, meaning Fastly may impress Wall Street when it announces third-quarter earnings on Oct. 27.</p>\n<p>Despite these recent headwinds, Fastly's financial performance looks a little more impressive over the long term.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2019 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Customers</p></td>\n   <td width=\"156\"><p>1,627</p></td>\n   <td width=\"156\"><p>2,581</p></td>\n   <td width=\"156\"><p>26%</p></td>\n  </tr>\n  <tr>\n   <td width=\"156\"><p>Revenue</p></td>\n   <td width=\"156\"><p>$169.4 million</p></td>\n   <td width=\"156\"><p>$323.2 million</p></td>\n   <td width=\"156\"><p>38%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: Fastly&nbsp;SEC&nbsp;Filings, YCharts. TTM = trailing 12 months. CAGR = compound annual growth rate.</p>\n<p>Looking ahead, Fastly has plenty of room to grow its business and management is executing on several opportunities. Last year, the company acquired Signal Sciences, broadening its security portfolio. During the most recent quarter, Fastly launched a beta version of the Signal Sciences agent on its edge cloud, and it introduced its first managed security offering. Collectively, these services help the company further differentiate itself from rivals.</p>\n<p>Fastly is also seeing traction with its Compute@Edge product, a new service that enables developers to build applications directly on Fastly's network. Compared to rival solutions, Compute@Edge offers 100 times&nbsp;faster code execution, which means better performance for end users. And during the most recent quarter, Fastly added new customers across a range of industries, from gaming to e-commerce.</p>\n<h2>The potential for threefold returns</h2>\n<p>Fastly still has a lot to prove, and investors should monitor its ability to add new customers. But the world is only becoming more digital, and that should create demand for Fastly's edge cloud in the coming years.</p>\n<p>More to the point, with a market cap of $4.7 billion, Fastly is three times smaller than Akamai. But if the company can maintain its top-line momentum, its share price could easily triple in the next five years. That's why now looks like a good time to add this growth stock to your portfolio.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Market Sell-Off: 1 Tech Stock That Could Triple in 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarket Sell-Off: 1 Tech Stock That Could Triple in 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-04 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/04/market-sell-off-1-tech-stock-that-could-triple/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Last week, all three major U.S. indices took a hit, though the tech-heavy Nasdaq Composite fell further than the S&P 500 or the Dow Jones Industrial Average. Unfortunately, this sell-off added to the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/04/market-sell-off-1-tech-stock-that-could-triple/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FSLY":"Fastly, Inc."},"source_url":"https://www.fool.com/investing/2021/10/04/market-sell-off-1-tech-stock-that-could-triple/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172799574","content_text":"Last week, all three major U.S. indices took a hit, though the tech-heavy Nasdaq Composite fell further than the S&P 500 or the Dow Jones Industrial Average. Unfortunately, this sell-off added to the pain of previous losses for some shareholders, myself included. For instance, Fastly (NYSE:FSLY) stock is now down about 70% from its all-time high.\nHowever, dips in the market can be buying opportunities when we are talking about a good company, especially if the company in question still has strong prospects for future growth. And I think Fastly checks that box. In fact, I think this tech stock could grow threefold in the next five years.\nHere's why.\nThe promise of edge computing\nFastly makes the internet faster. Its edge cloud platform accelerates and secures the delivery of content (e.g. applications, streaming media), ensuring a good experience for end-users like you and me. To do this, Fastly's global network -- composed of servers strategically positioned near internet exchange points -- sits between its customers' data centers and their end users' devices, effectively reducing the distance data must travel to reach its destination.\nWhy does this matter? Latency makes for a poor user experience. If a website or mobile app loads too slowly, people tend to abandon the service. This truth is made more pressing by digital transformation. As more companies engage with consumers through the internet, providing a high-quality digital experience becomes more critical.\nTo that end, Fastly puts its market opportunity at $36.2 billion by 2022.\nCompetitive position\nFastly built its edge cloud for the modern internet. Its network is composed of fewer, more powerful servers than traditional content delivery networks like Akamai. That means its edge cloud can handle more requests more quickly, so fewer requests are routed back to the client's data center. In turn, that translates into better performance and cost savings.\nFastly also benefits from its cloud-agnostic position, meaning its platform is not associated with or biased toward any public cloud, like Microsoft Azure or Amazon Web Services (AWS). Fastly works with all of them, intelligently routing traffic across different infrastructures. This means its clients can work with their preferred cloud vendors while monitoring all networks from a single platform.\nFinancial performance\nDuring the second quarter of 2021, an outage in Fastly's network caused a significant disruption for many websites, leading the company to post lackluster financial results. Revenue grew just 14%, and management lowered guidance for the third quarter. Even worse, CEO Joshua Bixby noted that a large customer had not yet returned to the platform as of the Q2 earnings call.\nAccording to CDN Planet, this unnamed customer is likely Amazon, since the retail giant stopped using Fastly shortly after the outage. However, Amazon did return to the platform in August, meaning Fastly may impress Wall Street when it announces third-quarter earnings on Oct. 27.\nDespite these recent headwinds, Fastly's financial performance looks a little more impressive over the long term.\n\n\n\nMetric\nQ2 2019 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nCustomers\n1,627\n2,581\n26%\n\n\nRevenue\n$169.4 million\n$323.2 million\n38%\n\n\n\nSource: Fastly SEC Filings, YCharts. TTM = trailing 12 months. CAGR = compound annual growth rate.\nLooking ahead, Fastly has plenty of room to grow its business and management is executing on several opportunities. Last year, the company acquired Signal Sciences, broadening its security portfolio. During the most recent quarter, Fastly launched a beta version of the Signal Sciences agent on its edge cloud, and it introduced its first managed security offering. Collectively, these services help the company further differentiate itself from rivals.\nFastly is also seeing traction with its Compute@Edge product, a new service that enables developers to build applications directly on Fastly's network. Compared to rival solutions, Compute@Edge offers 100 times faster code execution, which means better performance for end users. And during the most recent quarter, Fastly added new customers across a range of industries, from gaming to e-commerce.\nThe potential for threefold returns\nFastly still has a lot to prove, and investors should monitor its ability to add new customers. But the world is only becoming more digital, and that should create demand for Fastly's edge cloud in the coming years.\nMore to the point, with a market cap of $4.7 billion, Fastly is three times smaller than Akamai. But if the company can maintain its top-line momentum, its share price could easily triple in the next five years. That's why now looks like a good time to add this growth stock to your portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":17,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861454282,"gmtCreate":1632533855946,"gmtModify":1632710379900,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>At the very beginning ....... meant to be?&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>At the very beginning ....... meant to be?&nbsp;","text":"$Tiger Brokers(TIGR)$At the very beginning ....... meant to be?","images":[{"img":"https://static.tigerbbs.com/0dbe7ca914c714688a362f77cdaa4d25","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/861454282","isVote":1,"tweetType":1,"viewCount":47,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":878899472,"gmtCreate":1637163291892,"gmtModify":1637163291989,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"yeah weird .... the report is of no surprise.... it is expected to be loss.... haha the share price already accounted for this result&nbsp;[白眼]&nbsp;","listText":"yeah weird .... the report is of no surprise.... it is expected to be loss.... haha the share price already accounted for this result&nbsp;[白眼]&nbsp;","text":"yeah weird .... the report is of no surprise.... it is expected to be loss.... haha the share price already accounted for this result [白眼]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878899472","repostId":"878176795","repostType":1,"repost":{"id":878176795,"gmtCreate":1637162223118,"gmtModify":1637162223273,"author":{"id":"4096337009824130","authorId":"4096337009824130","name":"LWKJKK","avatar":"https://static.tigerbbs.com/c8865fe58cb1e2421bb5f60a39a8af3e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IQ\">$iQiyi Inc.(IQ)$</a>its crazy, took 2 months to rise to 8.5, then now back again. Guess need to wait for CNY for this to soar again.","listText":"<a href=\"https://laohu8.com/S/IQ\">$iQiyi Inc.(IQ)$</a>its crazy, took 2 months to rise to 8.5, then now back again. Guess need to wait for CNY for this to soar again.","text":"$iQiyi Inc.(IQ)$its crazy, took 2 months to rise to 8.5, then now back again. Guess need to wait for CNY for this to soar again.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878176795","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":337,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854498080,"gmtCreate":1635471993185,"gmtModify":1635471993541,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>My 1st heart break 😢","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>My 1st heart break 😢","text":"$Tiger Brokers(TIGR)$My 1st heart break 😢","images":[{"img":"https://static.tigerbbs.com/b99724357930fa0128ee07e029d9e556","width":"1080","height":"3617"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/854498080","isVote":1,"tweetType":1,"viewCount":49,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":855437327,"gmtCreate":1635389129376,"gmtModify":1635389241231,"author":{"id":"4093674933944970","authorId":"4093674933944970","name":"Desna10","avatar":"https://static.tigerbbs.com/ffc9d9e9c0984fe25e6364e1bfa3d540","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>888 good.... time to rise","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>888 good.... time to rise","text":"$Tiger Brokers(TIGR)$888 good.... time to rise","images":[{"img":"https://static.tigerbbs.com/11935c48b33810451b2ebeefcf1efcd0","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855437327","isVote":1,"tweetType":1,"viewCount":63,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"lives":[]}